ATE554066T1 - Entzündungshemmende substituierte cyclobutendionverbindungen - Google Patents

Entzündungshemmende substituierte cyclobutendionverbindungen

Info

Publication number
ATE554066T1
ATE554066T1 AT08760484T AT08760484T ATE554066T1 AT E554066 T1 ATE554066 T1 AT E554066T1 AT 08760484 T AT08760484 T AT 08760484T AT 08760484 T AT08760484 T AT 08760484T AT E554066 T1 ATE554066 T1 AT E554066T1
Authority
AT
Austria
Prior art keywords
compounds
cyclobutendione
inflammatory
substituted
inflammatory substituted
Prior art date
Application number
AT08760484T
Other languages
English (en)
Inventor
Neil John Press
Simon James Watson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE554066T1 publication Critical patent/ATE554066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08760484T 2007-06-06 2008-06-04 Entzündungshemmende substituierte cyclobutendionverbindungen ATE554066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109704 2007-06-06
PCT/EP2008/056902 WO2008148790A1 (en) 2007-06-06 2008-06-04 Anti -inflammatory substituted cyclobutenedione compounds

Publications (1)

Publication Number Publication Date
ATE554066T1 true ATE554066T1 (de) 2012-05-15

Family

ID=38626949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08760484T ATE554066T1 (de) 2007-06-06 2008-06-04 Entzündungshemmende substituierte cyclobutendionverbindungen

Country Status (13)

Country Link
US (1) US8183281B2 (de)
EP (1) EP2155670B1 (de)
JP (1) JP2010529079A (de)
KR (1) KR20100031718A (de)
CN (1) CN101772485A (de)
AT (1) ATE554066T1 (de)
AU (1) AU2008258588B2 (de)
BR (1) BRPI0812222A2 (de)
CA (1) CA2689581A1 (de)
EA (1) EA200901612A1 (de)
ES (1) ES2386489T3 (de)
MX (1) MX2009013276A (de)
WO (1) WO2008148790A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA103198C2 (en) * 2008-08-04 2013-09-25 Новартис Аг Squaramide derivatives as cxcr2 antagonists
US8648118B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted amide functionalised phenols as medicaments
US8648070B2 (en) * 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
ES2655942T3 (es) 2011-09-02 2018-02-22 Novartis Ag Sal de colina de un compuesto anti-inflamatorio de ciclobutenodiona sustituida
FR2981934B1 (fr) * 2011-10-28 2013-12-20 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
FR2981935B1 (fr) * 2011-10-28 2015-08-07 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
CZ2014321A3 (cs) * 2014-05-09 2016-01-13 Vysoká škola chemicko- technologická v Praze Dioxocyklobutenylhydrazony a jejich protirakovinné účinky
FR3030515B1 (fr) * 2014-12-23 2017-01-20 Galderma Res & Dev Nouveaux composes antagonistes des recepteurs cxcr1 et cxcr2 aux chimiokines, et leur utilisation dans le traitement de pathologies mediees par des chimiokines
TWI734715B (zh) 2015-11-19 2021-08-01 美商卡默森屈有限公司 趨化因子受體調節劑
TWI724056B (zh) 2015-11-19 2021-04-11 美商卡默森屈有限公司 Ｃｘｃｒ２抑制劑
KR20200037857A (ko) 2017-08-14 2020-04-09 알러간, 인코포레이티드 3,4-이치환된 3-시클로부텐-1,2-디온 및 그의 용도
EP3737366B1 (de) 2018-01-08 2026-02-25 ChemoCentryx, Inc. Verfahren zur behandlung von generalisierter pustulöser psoriasis mit einem antagonisten von ccr6 oder cxcr2
SG11202101827RA (en) 2018-09-21 2021-04-29 Pfizer N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
CN109824629B (zh) * 2019-02-27 2022-12-09 南京工业大学 一种利用N-乙酰氨基葡萄糖制备3-氨基-5-(α-氨基乙基)四氢呋喃的方法
AU2020338971B2 (en) 2019-08-28 2023-11-23 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
CN112759549B (zh) * 2019-11-05 2023-07-28 中国医学科学院药物研究所 3-取代氨基-4-((取代吡啶基)氨基)环丁-3-烯-1,2-二酮类化合物
CN112851635B (zh) * 2019-11-28 2022-09-16 中国医学科学院药物研究所 环状砜类化合物及其制备方法、用途和药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166050A (en) * 1998-12-14 2000-12-26 American Home Products Corporation 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by VLA-4
DE60216229T2 (de) 2001-01-16 2007-10-04 Smithkline Beecham Corp. Il-8-rezeptorantagonisten
US20040106794A1 (en) 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
CN1289471C (zh) * 2001-04-16 2006-12-13 先灵公司 作为cxc－趋化因子受体配体的3,4－二取代的环丁烯－1,2－二酮
US7132445B2 (en) 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
WO2003080053A1 (en) 2002-03-18 2003-10-02 Schering Corporation Combination treatments for chemokine-mediated diseases

Also Published As

Publication number Publication date
EA200901612A1 (ru) 2010-06-30
JP2010529079A (ja) 2010-08-26
AU2008258588B2 (en) 2011-11-10
WO2008148790A1 (en) 2008-12-11
AU2008258588A8 (en) 2010-05-13
EP2155670B1 (de) 2012-04-18
US20100125071A1 (en) 2010-05-20
AU2008258588A1 (en) 2008-12-11
KR20100031718A (ko) 2010-03-24
BRPI0812222A2 (pt) 2014-12-16
WO2008148790A8 (en) 2010-01-07
ES2386489T3 (es) 2012-08-21
CN101772485A (zh) 2010-07-07
EP2155670A1 (de) 2010-02-24
US8183281B2 (en) 2012-05-22
MX2009013276A (es) 2010-01-25
CA2689581A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
ECSP10010722A (es) Compuestos orgánicos
CR11021A (es) Derivados de quinolina como fungicidas
UA107791C2 (en) Pesticidal compositions
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
EA201070519A1 (ru) Соединения тропана
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201101148A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201101060A1 (ru) Новые гербициды
UA106880C2 (uk) Нові гербіциди
EA201101146A1 (ru) Новые гербициды
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
UY31688A1 (es) Plaguicidas
ATE483000T1 (de) Naphtalin-amidin-imide
EA201101097A1 (ru) Новые микробиоциды
EA201000069A1 (ru) Новые гербициды
DE602006009789D1 (de) Acetylenderivate
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина